Walter E. Washington Convention Center
Washington, D.C.
May 16-19, 2022

Oxford Biomedica  

United Kingdom
  • Booth: 240

Our goal is to become an integrated, self-financing gene and cell therapy business.Using our unique LentiVector® delivery platform, we have created a valuable portfolio of gene and cell therapy product candidates in the areas of oncology, ophthalmology and CNS disorders.